Zoetis Inc. Appoints James Saccaro as EVP, CFO & COO; Prior CFO to Transition

What Happened

• Zoetis announced the appointment of James Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Mr. Saccaro (age 53) joins from GE HealthCare Technologies, where he has been VP and CFO since June 2023, and previously served as CFO of Baxter International (2015–2023). He will be the company’s principal financial officer and principal accounting officer and will also oversee Global Manufacturing and Supply.
• The company also disclosed the departure plan for current EVP & CFO Wetteny Joseph. Under a July 31, 2026 letter agreement, Mr. Joseph will transition from his CFO role after August 16, 2026 and remain employed as a non‑executive through the earlier of February 28, 2027 or a mutually agreed date to assist with the transition.

Key Details

• Effective date: James Saccaro — August 17, 2026; Offer Letter dated July 31, 2026.
• Pay and incentives for Saccaro: $1,000,000 annual base salary; annual target bonus = 100% of base (2026 bonus to be paid at target and prorated); annual long‑term incentive target = $5,000,000 (currently 50% PSUs, 25% RSUs, 25% options).
• Make‑whole awards for Saccaro: one‑time RSU award valued at $6,250,000 vesting one‑third on each of the first three anniversaries; one‑time cash make‑whole award of $1,250,000 (subject to repayment if employment terminates under certain circumstances within first year).
• Wetteny Joseph transition terms: will continue base pay, benefits, and vesting until termination; eligible for 2026 incentive based on target and company funding; upon termination, eligible for Executive Severance Plan benefits and his equity treated as a “Restructuring Event.” Company states his departure was not due to any disagreement with the company.

Why It Matters

• This is a material leadership change in Zoetis’ finance and operations — the new executive will be the company’s principal financial and accounting officer and will also run manufacturing and supply, which could affect capital allocation, reporting emphasis, and operational execution.
• Compensation details show the company is making a significant investment to recruit an experienced senior finance executive, and the structured transition for the outgoing CFO aims to provide continuity through early 2027. Investors should note the appointment date and transition timeline for any near‑term investor communications, financial reporting responsibilities, or updates to guidance.